๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Neoadjuvant Chemoimmunotherapy

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05) NCT07165847Phase 21 site๐Ÿ“ Chongqing Daping Hospital and the Research Institute of Surgery of thโ€ฆ ยท Tests: Iparomlimab and Tuvonralimab, Oxaliplatin, Tegafur, Radiotherapy A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs) NCT07743190Phase 22 sites๐Ÿ“ Syracuse๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Carboplatin, Paclitaxcel, Pembrolizumab RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC NCT07541521n/a10 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen Shanghai Chest Hospital ยท Tests: Robot-assisted thoracoscopic surgery (RATS) sleeve lobectomy Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy NCT07111455n/a1 site๐Ÿ“ Guangzhou Zhujiang Hospital Tafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer NCT07840677Phase 21 site๐Ÿ“ Chongqing Daping Hospital and the Research Institute of Surgery of thโ€ฆ ยท Tests: Tafolecimab, Sintilimab Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma๏ผˆCRIS-2 Trial๏ผ‰ NCT06509568Phase 21 site๐Ÿ“ Hangzhou Zhejiang Cancer Hospital ยท Tests: Neoadjuvant chemoradiotherapy followed by immunotherapy, Neoadjuvant chemoimmunotherapy Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer NCT07646301Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Iparomlimab and Tuvonralimab (QL1706), Paclitaxel, Cisplatin, Carboplatin NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients NCT06845319Phase 21 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Carboplatin, Paclitaxel, Pembrolizumab Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer NCT06289751Phase 22 sites๐Ÿ“ Wuhan๐Ÿ“ Jinan Tongji Hospital ยท Tests: Cadonilimab, Paclitaxel-albumin, Cisplatin, Extrafascial hysterectomy, Radical hysterectomy HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer NCT06709885Phase 21 site๐Ÿ“ Chongqing Daping Hospital and the Research Institute of Surgery of thโ€ฆ ยท Tests: Chidamide + Tislelizumab + chemotherapy (CapeOX ), CapeOX Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung Cancer NCT07855965Phase 29 sites๐Ÿ“ Chengdu๐Ÿ“ Chengdu๐Ÿ“ Chengdu West China Hospital ยท Tests: Cryo-Thermal Ablation, Toripalimab, Platinum-based doublet chemotherapy Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer NCT06879704NA1 site๐Ÿ“ Rouen Centre Henri Becquerel ยท Tests: Imaging assessment Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE NCT07559123n/a1 site๐Ÿ“ Seoul Samsung Medical Center ยท Tests: High-resolution deep learning-based CT reconstruction Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer NCT07063901n/a1 site๐Ÿ“ Changsha Central South University Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02) NCT07317609Phase 11 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: Tislelizumab, Carboplatin, Nab-paclitaxel, Endoscopic resection, Esophagectomy Neoadjuvant Immunochemotherapy in PD-L1-negative LACC NCT06288360Phase 212 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Chongqing Tongji Hospital ยท Tests: Camrelizumab, Paclitaxel-albumin, Cisplatin, radical surgery Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma NCT05740995n/a1 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: neoadjuvant anti-PD-1 plus chemotherapy Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC NCT06623656Phase 21 site๐Ÿ“ New York Weill Medical College of Cornell University ยท Tests: Cemiplimab, Platinum based chemotherapy, Stereotactic body radiation therapy A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer NCT06800339Phase 14 sites๐Ÿ“ Baltimore๐Ÿ“ Baltimore๐Ÿ“ Bel Air University of Maryland, Baltimore ยท Tests: Nivolumab, Chemotherapy, SBRT, Surgical Resection dCRT vs. Surgery in Resectable ESCC Patients Achieving cCR/PR After Induction Chemoimmunotherapy NCT07162506Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Surgery, Radiotherapy, Chemotherapy, Immunotherapy NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study NCT07121374Phase 1, Phase 21 site๐Ÿ“ Edegem University Hospital, Antwerp ยท Tests: Neoadjuvant chemo-immunotherapy, Extended pleurectomy/decortication in case of reaching operability Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer NCT07534033Phase 21 site๐Ÿ“ Guangzhou Zhujiang Hospital ยท Tests: Probiotics combined with neoadjuvant chemoimmunotherapy Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC NCT07528066n/a10 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen Shanghai Chest Hospital ยท Tests: Robotic-assisted surgery (RATS) TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy NCT07330037Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: L-TIL cells injection, Tislelizumab Node-Sparing Short-Course Radiotherapy (25 Gy/5 Fractions) Combined With Chemoimmunotherapy as Neoadjuvant Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma๏ผšA Prospective Single-Arm, Phase II Study NCT07808853Phase 21 site๐Ÿ“ Guanzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Neoadjuvant SCRT + Camrelizumab + Nab-Paclitaxel/Carboplatin Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer NCT06421376Phase 23 sites๐Ÿ“ Anyang๐Ÿ“ Xinxiang๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Cardonilizumab, Chemoradiotherapy ยฑimmunotherapy, Radical surgery Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy NCT06602843NA1 site๐Ÿ“ Hefei Anhui Provincial Hospital ยท Tests: Neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC NCT06424899Phase 21 site๐Ÿ“ Hangzhou Zeng Jian ยท Tests: Adebrelimab, radical chemoradiotherapy, Platinum based chemotherapy Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma NCT06907602Phase 2, Phase 31 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Chemotherapy, Immunotherapy (Pembrolizumab), radiotherapy Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer NCT07478900NA1 site๐Ÿ“ Bhubaneswar All India Institute of Medical Sciences, Bhubaneswar ยท Tests: Skin Tattooing of Tumor Margins Prior to Neoadjuvant Chemotherapy in Breast Cancer Patients: Prospective cohort study
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy